Botulinum toxin in urology: evaluation using an evidence-based medicine approach (Q36395007)

13 August 2017

1 reference

title

Botulinum toxin in urology: evaluation using an evidence-based medicine approach (English)

1 reference

13 August 2017

main subject

evidence-based medicine

1 reference

Christopher P Smith

1

1 reference

13 August 2017

George T Somogyi

series ordinal

2

1 reference

13 August 2017

Timothy B Boone

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

13 August 2017

published in

Nature Reviews Urology

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

31-37

1 reference

Emerging role of botulinum toxin in the management of voiding dysfunction

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Botulinum toxin type B for type A resistant bladder spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Treatment of neuropathic bladder using botulinum toxin A in a 1-year-old child with myelomeningocele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

Prevalence and burden of overactive bladder in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Agency for Health Care Policy and Research clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum A Toxin Urethral Injection for the Treatment of Lower Urinary Tract Dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Prognostic value of urodynamic testing in myelodysplastic patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Treatment of overactive bladder with botulinum toxin type B: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0034

7 January 2021

Identifiers

DOI

10.1038/NCPURO0034

1 reference

Dimensions Publication ID

13 August 2017

1018496917

0 references

1 reference